- Filed
- May 1, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 28, 2025 | 113.1M sh |
| Long Term Debt | Q1 2025 · Mar 28, 2025 | $111.35M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $112.08M |
| Current Liabilities | Q1 2025 · Mar 28, 2025 | $165.22M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $167.57M |
| Total Liabilities | Q1 2025 · Mar 28, 2025 | $327.62M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $331.25M |
| Current Assets | Q1 2025 · Mar 28, 2025 | $340.69M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $366.08M |
| Total Assets | Q1 2025 · Mar 28, 2025 | $773.75M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $796.51M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $101.46M |
| Cash And Equivalents | Q1 2025 · Mar 29, 2024 | $84.31M |
| Shares Diluted | Q1 2025 · Mar 29, 2024 | 112.35M sh |
| Stock Repurchased | Q1 2025 · Mar 29, 2024 | $21.68M |
| Capex | Q1 2025 · Mar 29, 2024 | $1.91M |
| Operating Cash Flow | Q1 2025 · Mar 29, 2024 | $26.82M |
| Stockholders Equity | Q1 2025 · Mar 29, 2024 | $409.15M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $436.87M |
| Eps Diluted | Q1 2025 · Mar 29, 2024 | −$0.07 |
| Eps Basic | Q1 2025 · Mar 29, 2024 | −$0.07 |
| Sga Expense | Q1 2025 · Mar 29, 2024 | $38.87M |
| Rd Expense | Q1 2025 · Mar 29, 2024 | $30.71M |
| Net Income | Q1 2025 · Mar 29, 2024 | −$8.09M |
| Operating Income | Q1 2025 · Mar 29, 2024 | −$9.53M |
| Gross Profit | Q1 2025 · Mar 29, 2024 | $63.08M |
| Cost Of Revenue | Q1 2025 · Mar 29, 2024 | $58.98M |
| Revenue | Q1 2025 · Mar 29, 2024 | $122.06M |